McKesson Corporation (MCK)

NYSE: MCK · IEX Real-Time Price · USD
525.88
+4.47 (0.86%)
At close: Mar 1, 2024, 4:00 PM
526.10
+0.22 (0.04%)
After-hours: Mar 1, 2024, 7:59 PM EST
0.86%
Market Cap 69.10B
Revenue (ttm) 301.51B
Net Income (ttm) 3.00B
Shares Out 131.41M
EPS (ttm) 22.09
PE Ratio 23.81
Forward PE 17.99
Dividend $2.48 (0.47%)
Ex-Dividend Date Feb 29, 2024
Volume 721,497
Open 523.51
Previous Close 521.41
Day's Range 522.74 - 531.26
52-Week Range 331.75 - 531.19
Beta 0.44
Analysts Buy
Price Target 508.31 (-3.34%)
Earnings Date Feb 7, 2024

About MCK

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt... [Read more]

Sector Healthcare
Founded 1833
Employees 51,000
Stock Exchange NYSE
Ticker Symbol MCK
Full Company Profile

Financial Performance

In 2022, McKesson's revenue was $276.71 billion, an increase of 4.83% compared to the previous year's $263.97 billion. Earnings were $3.56 billion, an increase of 219.57%.

Financial Statements

Analyst Forecast

According to 13 analysts, the average rating for MCK stock is "Buy." The 12-month stock price forecast is $508.31, which is a decrease of -3.34% from the latest price.

Price Target
$508.31
(-3.34% downside)
Analyst Consensus: Buy
Stock Forecasts

News

McKesson's Practice Insights Designated as a 2024 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services

IRVING, Texas--(BUSINESS WIRE)--McKesson received approval from CMS to participate in the Merit-based Incentive Payment System as a Qualified Clinical Data Registry for the 8th year.

24 days ago - Business Wire

McKesson raises annual profit forecast on strong demand for specialty medicines

U.S.-based drug distributor McKesson raised its annual profit forecast on Wednesday, banking on strong demand for specialty medicines.

25 days ago - Reuters

McKesson Corporation Reports Fiscal 2024 Third Quarter Results and Raises Full Year Guidance

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2024 third quarter financial results. Results can be accessed on McKesson's Investor Relations website at inves...

25 days ago - Business Wire

McKesson Corporation Declares Quarterly Dividend

IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 62 cents per share of common stock. The dividend will be payable on A...

4 weeks ago - Business Wire

Charts turn bullish on health-care stocks as sector takes early lead in 2024

Chart-watchers are growing increasingly bullish on health-care stocks now that they have become the best-performing sector of the S&P 500 so far in 2024, according to Dow Jones Market Data. Analysts h...

6 weeks ago - Market Watch

US drug retailer McKesson seeks buyers for Canada's Rexall Pharmacy -source

McKesson Corp is planning to sell Canadian drugstore chain Rexall Pharmacy Group, a source familiar with the process told Reuters on Friday, seven years after the U.S. drug distributor bought the busi...

7 weeks ago - Reuters

McKesson to Present at the 42nd Annual J.P. Morgan Healthcare Conference

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will present at the 42nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco today at 9:45 AM PT ...

7 weeks ago - Business Wire

McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January Conference

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2024 financial results after market close on Wednesday, February 7, 2024. The company will host a...

2 months ago - Business Wire

Edifecs Appoints Former McKesson Leader, Stephen Ayers, as Chief Financial Officer

BELLEVUE, Wash.--(BUSINESS WIRE)--Edifecs, Inc., a global health information technology solutions company, announced today the addition of Stephen Ayers to its leadership team as chief financial offic...

3 months ago - Business Wire

McKesson lifts annual profit forecast after strong quarterly results

Drug distributor McKesson Corp on Wednesday raised its annual profit forecast, banking on strong demand for specialty medicines.

4 months ago - Reuters

McKesson Corporation Reports Fiscal 2024 Second Quarter Results and Raises Full Year Guidance

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2024 second quarter financial results. Results can be accessed on McKesson's Investor Relations website at inve...

4 months ago - Business Wire

McKesson Aims For The $500 Milestone After Shattering Previous Record Highs And Outperforming The S&P 500! - McKesson (NYSE:MCK)

McKesson Corp's MCK impressive performance stands out amidst a decline in the S&P 500 index.

4 months ago - Benzinga

Bankrupt Rite Aid resolves drug supply dispute with McKesson

Pharmacy chain Rite Aid has settled a critical dispute with drug supplier McKesson Corp to ensure that customers' prescriptions will continue to be filled during Rite Aid's bankruptcy, attorneys said ...

Other symbols: RADCQ
4 months ago - Reuters

McKesson doesn't expect Rite Aid's bankruptcy to have much affect on profit outlook, liquidity

McKesson Corp. MCK, +0.73% disclosed Monday that it doesn't expect drugstore chain Rite Aid Corp.'s RAD, -16.81% bankruptcy announced over the weekend to have a material impact on its adjusted earning...

4 months ago - Market Watch

Eli Lilly, McKesson, Novartis Flash Promising Chart Action

Although healthcare stocks lag other sectors, large-cap leaders such as  Eli Lilly & Co. NYSE: LLY, McKesson Corp. NYSE: MCK and Novartis AG NYSE: NVS  are in possible buy ranges as they get moving-av...

Other symbols: LLYNVS
5 months ago - MarketBeat

McKesson Corporation Announces Second Quarter Fiscal 2024 Earnings Release Date

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2024 financial results after market close on Wednesday, November 1, 2023. The company will host ...

5 months ago - Business Wire

Genpact Extends Relationship to Transform McKesson's Finance Operations for Enhanced Service and Competitive Growth

Companies co-innovate with leading-edge technologies, advanced analytics, and improved process design to drive strategic business value with McKesson's digital finance operating model optimization  IR...

Other symbols: G
7 months ago - PRNewsWire

Buffett bet on home builders and retreated from videogames during the second quarter

Warren Buffett's Berkshire Hathaway Inc. took new stakes in home builders, bulked up on Capital One Financial Corp. and backed away from Activision Blizzard Inc. in the second quarter, according to qu...

Other symbols: ATVICOFCVXDHIGMLENNVR
7 months ago - Market Watch

Warren Buffett's Berkshire Hathaway bet on 3 homebuilders - and sold and slashed a bunch of stocks last quarter

Warren Buffett's Berkshire Hathaway added a trio of homebuilders to its portfolio last quarter. The investor's company exited three stocks and slashed several of its positions, SEC filings show.

Other symbols: ATVICECVXDHIGLGMLEN
7 months ago - Business Insider

McKesson Medical-Surgical Supports National Health Center Week 2023

RICHMOND, Va.--(BUSINESS WIRE)--McKesson Medical-Surgical is a silver sponsor of the National Association of Community Health Centers 2023 NHCW Aug. 6-12.

7 months ago - Business Wire

McKesson Corporation Reports Fiscal 2024 First Quarter Results

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2024 first quarter financial results. Results can be accessed on McKesson's Investor Relations website at inves...

7 months ago - Business Wire

McKesson boosts quarterly dividend 15%

McKesson Corp. MCK, -1.08% said Monday that it raised its quarterly dividend declared July 21 to $0.62 per share, a 15% increase from $0.54 per share in the prior quarter. “The dividend increase refle...

7 months ago - Market Watch

McKesson Raises Quarterly Dividend by 15% to $0.62 Per Share

IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) declared on July 21, 2023 a regular dividend of $0.62 per share of common stock, a 15% increase from $0.54 per...

7 months ago - Business Wire

McKesson Corporation Announces First-Quarter Fiscal 2024 Earnings Release Date

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first-quarter fiscal 2024 financial results after market close on Wednesday, August 2, 2023. The company will host a l...

8 months ago - Business Wire

McKesson ideaShare Recognizes Excellence in Community Pharmacy

IRVING, Texas--(BUSINESS WIRE)--McKesson ideaShare 2023 drew more than 2,800 attendees including pharmacists, independent pharmacy owners, technicians, exhibitors and staff.

8 months ago - Business Wire